Tumor SOCS3 methylation status predicts the treatment response to TACE and prognosis in HCC patients

Published 2017 View Full Article

  1. Home
  2. Publications
  3. Publication Search
  4. Publication Details
Title
Tumor SOCS3 methylation status predicts the treatment response to TACE and prognosis in HCC patients
Authors
Keywords
suppressor of cytokine signaling, transarterial chemoembolization, methylation, prognosis
Journal
Oncotarget
Volume 8, Issue 17, Pages -
Publisher
Impact Journals, LLC
Online
2017-03-14
DOI
10.18632/oncotarget.16157

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Reprint

Contact the author

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Search
Webinars Posters Questions Hubs Funding Journals Articles Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.